FACTX
Price
$48.60
Change
-$0.86 (-1.74%)
Updated
Apr 3 closing price
Net Assets
3.74B
FSPHX
Price
$26.50
Change
-$0.46 (-1.71%)
Updated
Apr 3 closing price
Net Assets
6.42B
Ad is loading...

FACTX vs FSPHX

Header iconFACTX vs FSPHX Comparison
Open Charts FACTX vs FSPHXBanner chart's image
Fidelity Advisor Health Care M
Price$48.60
Change-$0.86 (-1.74%)
VolumeN/A
Net Assets3.74B
Fidelity Select Health Care
Price$26.50
Change-$0.46 (-1.71%)
VolumeN/A
Net Assets6.42B
FACTX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FACTX vs. FSPHX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FACTX is a Buy and FSPHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.42B vs. FACTX (3.74B). FSPHX pays higher dividends than FACTX: FSPHX (0.02) vs FACTX (0.00). FACTX was incepted earlier than FSPHX: FACTX (29 years) vs FSPHX (44 years). FACTX (1.18) is less costly to investors than FSPHX (0.65). FSPHX is a more actively managed with annual turnover of: 46.00 vs. FACTX (37.00). FACTX (0) and FSPHX (0) have matching initial minimum investment requirements. FSPHX annual gain was more profitable for investors over the last year : -10.48 vs. FACTX (-13.54). FACTX return over 5 years is better than : 9.58 vs. FSPHX (8.70).
FACTXFSPHXFACTX / FSPHX
Total Expense Ratio1.180.65182%
Annual Report Gross Expense Ratio1.180.65182%
Fund Existence29 years44 years-
Gain YTD-2.498-2.385105%
Front Load4%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets3.74B6.42B58%
Annual Yield % from dividends0.000.02-
Returns for 1 year-13.54-10.48129%
Returns for 3 years-13.77-11.35121%
Returns for 5 years9.588.70110%
Returns for 10 years20.3910.70191%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MTCCX38.750.31
+0.81%
MFS Technology C
OCSGX6.03N/A
N/A
Optimum Small-Mid Cap Growth C
PEIOX38.93N/A
N/A
Principal Equity Income R3
GGEIX21.85N/A
N/A
Nationwide Global Sust Eq R6
AXVIX16.88N/A
N/A
Acclivity Small Cap Value I